Hadrontherapy from the Italian Radiation Oncologist point of view: face the reality. The Italian Society of Oncological Radiotherapy (AIRO) survey.

Giulia Marvaso, Barbara Vischioni, Barbara Alicja Jereczek-Fossa, Delia Ciardo, Piero Fossati, Tommaso Giandini, Sara Morlino, Mauro Carrara, Paola Romanelli, Elvio G. Russi, Francesca Valvo, Riccardo Valdagni, Roberto Orecchia

Research output: Contribution to journalArticle

Abstract

Hadrontherapy has been in constant progress in the past decades. Due to the increasing interest in this field and the spreading of the technique in Italy and worldwide, the Italian Society of Radiation Oncology surveyed (by an online survey) its members regarding their perception of hadrontherapy. The survey outline addressed different items all related to hadrontherapy, such as: demographics (3 items), personal knowledge (5 items), actual use in clinical practice (5 items), and future perspectives and development (5 items). The survey was filled in by 224 radiation oncologists (RO). Among them, 74.6 % were RO with more than 5 years of clinical practice, and only 10.4 % RO in training. Median age was 46 years (range 27-77). 32.24 % admitted average knowledge about heavy particles radiobiology rationale and 32.42 % about the ongoing particle therapy clinical trials. Radioresistant tumors are perceived as-principal indications for carbon ions in 39.3 % of responders, and pediatric malignancies for protons in 37 Re-irradiation is highly recommended for 52.2 Strikingly, 38.8 % of participating ROs reported that, in the daily clinical practice, approximately less than 1 out of 10 patients asks to be referred for hadrontherapy. On the other side, 35.7 % claimed need for at least 3 up to 5 particle therapy centers in Italy. Overall, the results of the present survey highlight the interest of the Italian RO community for particle therapy among the other radiotherapy technique. Analysis of our results might picture the clinical attitude of the RO community towards hadrontherapy in Italy, and help in promoting targeted initiatives to spread clinical results and knowledge about technical innovations in this field.
Original languageUndefined/Unknown
Pages (from-to)140-145
Number of pages6
JournalRadiologia Medica
Volume122
Issue number2
DOIs
Publication statusPublished - Feb 1 2017

Keywords

  • *Carbon ion, *Hadrontherapy, *Health Knowledge, Attitudes, Practice, *Heavy Ion Radiotherapy/instrumentation/methods, *Medical Oncology, *Proton therapy, *Radiation oncologist, *Survey, Adult, Aged, Carbon/therapeutic use, Female, Humans, Italy, Male, Middle Aged, Neoplasms/*radiotherapy, Protons/therapeutic use, Radiotherapy, Computer-Assisted/methods, Societies, Medical, Surveys and Questionnaires

Cite this

Hadrontherapy from the Italian Radiation Oncologist point of view: face the reality. The Italian Society of Oncological Radiotherapy (AIRO) survey. / Marvaso, Giulia; Vischioni, Barbara; Jereczek-Fossa, Barbara Alicja; Ciardo, Delia; Fossati, Piero; Giandini, Tommaso; Morlino, Sara; Carrara, Mauro; Romanelli, Paola; Russi, Elvio G.; Valvo, Francesca; Valdagni, Riccardo; Orecchia, Roberto.

In: Radiologia Medica, Vol. 122, No. 2, 01.02.2017, p. 140-145.

Research output: Contribution to journalArticle

Marvaso, Giulia ; Vischioni, Barbara ; Jereczek-Fossa, Barbara Alicja ; Ciardo, Delia ; Fossati, Piero ; Giandini, Tommaso ; Morlino, Sara ; Carrara, Mauro ; Romanelli, Paola ; Russi, Elvio G. ; Valvo, Francesca ; Valdagni, Riccardo ; Orecchia, Roberto. / Hadrontherapy from the Italian Radiation Oncologist point of view: face the reality. The Italian Society of Oncological Radiotherapy (AIRO) survey. In: Radiologia Medica. 2017 ; Vol. 122, No. 2. pp. 140-145.
@article{a53a6700044c4ff3bb5a3965132b3596,
title = "Hadrontherapy from the Italian Radiation Oncologist point of view: face the reality. The Italian Society of Oncological Radiotherapy (AIRO) survey.",
abstract = "Hadrontherapy has been in constant progress in the past decades. Due to the increasing interest in this field and the spreading of the technique in Italy and worldwide, the Italian Society of Radiation Oncology surveyed (by an online survey) its members regarding their perception of hadrontherapy. The survey outline addressed different items all related to hadrontherapy, such as: demographics (3 items), personal knowledge (5 items), actual use in clinical practice (5 items), and future perspectives and development (5 items). The survey was filled in by 224 radiation oncologists (RO). Among them, 74.6 {\%} were RO with more than 5 years of clinical practice, and only 10.4 {\%} RO in training. Median age was 46 years (range 27-77). 32.24 {\%} admitted average knowledge about heavy particles radiobiology rationale and 32.42 {\%} about the ongoing particle therapy clinical trials. Radioresistant tumors are perceived as-principal indications for carbon ions in 39.3 {\%} of responders, and pediatric malignancies for protons in 37 Re-irradiation is highly recommended for 52.2 Strikingly, 38.8 {\%} of participating ROs reported that, in the daily clinical practice, approximately less than 1 out of 10 patients asks to be referred for hadrontherapy. On the other side, 35.7 {\%} claimed need for at least 3 up to 5 particle therapy centers in Italy. Overall, the results of the present survey highlight the interest of the Italian RO community for particle therapy among the other radiotherapy technique. Analysis of our results might picture the clinical attitude of the RO community towards hadrontherapy in Italy, and help in promoting targeted initiatives to spread clinical results and knowledge about technical innovations in this field.",
keywords = "*Carbon ion, *Hadrontherapy, *Health Knowledge, Attitudes, Practice, *Heavy Ion Radiotherapy/instrumentation/methods, *Medical Oncology, *Proton therapy, *Radiation oncologist, *Survey, Adult, Aged, Carbon/therapeutic use, Female, Humans, Italy, Male, Middle Aged, Neoplasms/*radiotherapy, Protons/therapeutic use, Radiotherapy, Computer-Assisted/methods, Societies, Medical, Surveys and Questionnaires",
author = "Giulia Marvaso and Barbara Vischioni and Jereczek-Fossa, {Barbara Alicja} and Delia Ciardo and Piero Fossati and Tommaso Giandini and Sara Morlino and Mauro Carrara and Paola Romanelli and Russi, {Elvio G.} and Francesca Valvo and Riccardo Valdagni and Roberto Orecchia",
year = "2017",
month = "2",
day = "1",
doi = "10.1007/s11547-016-0699-1",
language = "Non definita",
volume = "122",
pages = "140--145",
journal = "Radiologia Medica",
issn = "0033-8362",
publisher = "Springer-Verlag Italia s.r.l.",
number = "2",

}

TY - JOUR

T1 - Hadrontherapy from the Italian Radiation Oncologist point of view: face the reality. The Italian Society of Oncological Radiotherapy (AIRO) survey.

AU - Marvaso, Giulia

AU - Vischioni, Barbara

AU - Jereczek-Fossa, Barbara Alicja

AU - Ciardo, Delia

AU - Fossati, Piero

AU - Giandini, Tommaso

AU - Morlino, Sara

AU - Carrara, Mauro

AU - Romanelli, Paola

AU - Russi, Elvio G.

AU - Valvo, Francesca

AU - Valdagni, Riccardo

AU - Orecchia, Roberto

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Hadrontherapy has been in constant progress in the past decades. Due to the increasing interest in this field and the spreading of the technique in Italy and worldwide, the Italian Society of Radiation Oncology surveyed (by an online survey) its members regarding their perception of hadrontherapy. The survey outline addressed different items all related to hadrontherapy, such as: demographics (3 items), personal knowledge (5 items), actual use in clinical practice (5 items), and future perspectives and development (5 items). The survey was filled in by 224 radiation oncologists (RO). Among them, 74.6 % were RO with more than 5 years of clinical practice, and only 10.4 % RO in training. Median age was 46 years (range 27-77). 32.24 % admitted average knowledge about heavy particles radiobiology rationale and 32.42 % about the ongoing particle therapy clinical trials. Radioresistant tumors are perceived as-principal indications for carbon ions in 39.3 % of responders, and pediatric malignancies for protons in 37 Re-irradiation is highly recommended for 52.2 Strikingly, 38.8 % of participating ROs reported that, in the daily clinical practice, approximately less than 1 out of 10 patients asks to be referred for hadrontherapy. On the other side, 35.7 % claimed need for at least 3 up to 5 particle therapy centers in Italy. Overall, the results of the present survey highlight the interest of the Italian RO community for particle therapy among the other radiotherapy technique. Analysis of our results might picture the clinical attitude of the RO community towards hadrontherapy in Italy, and help in promoting targeted initiatives to spread clinical results and knowledge about technical innovations in this field.

AB - Hadrontherapy has been in constant progress in the past decades. Due to the increasing interest in this field and the spreading of the technique in Italy and worldwide, the Italian Society of Radiation Oncology surveyed (by an online survey) its members regarding their perception of hadrontherapy. The survey outline addressed different items all related to hadrontherapy, such as: demographics (3 items), personal knowledge (5 items), actual use in clinical practice (5 items), and future perspectives and development (5 items). The survey was filled in by 224 radiation oncologists (RO). Among them, 74.6 % were RO with more than 5 years of clinical practice, and only 10.4 % RO in training. Median age was 46 years (range 27-77). 32.24 % admitted average knowledge about heavy particles radiobiology rationale and 32.42 % about the ongoing particle therapy clinical trials. Radioresistant tumors are perceived as-principal indications for carbon ions in 39.3 % of responders, and pediatric malignancies for protons in 37 Re-irradiation is highly recommended for 52.2 Strikingly, 38.8 % of participating ROs reported that, in the daily clinical practice, approximately less than 1 out of 10 patients asks to be referred for hadrontherapy. On the other side, 35.7 % claimed need for at least 3 up to 5 particle therapy centers in Italy. Overall, the results of the present survey highlight the interest of the Italian RO community for particle therapy among the other radiotherapy technique. Analysis of our results might picture the clinical attitude of the RO community towards hadrontherapy in Italy, and help in promoting targeted initiatives to spread clinical results and knowledge about technical innovations in this field.

KW - Carbon ion, Hadrontherapy, Health Knowledge, Attitudes, Practice, Heavy Ion Radiotherapy/instrumentation/methods, Medical Oncology, Proton therapy, Radiation oncologist, Survey, Adult, Aged, Carbon/therapeutic use, Female, Humans, Italy, Male, Middle Aged

U2 - 10.1007/s11547-016-0699-1

DO - 10.1007/s11547-016-0699-1

M3 - Articolo

VL - 122

SP - 140

EP - 145

JO - Radiologia Medica

JF - Radiologia Medica

SN - 0033-8362

IS - 2

ER -